UB
VRTX icon

UMB Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

UMB Bank’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$725K Sell
1,459
-148
-9% -$65.6K 0.01% 414
2026
Q1 		$718K Sell
1,607
-379
-19% -$177K 0.01% 410
2025
Q4 		$900K Buy
1,986
+148
+8% +$63.8K 0.01% 375
2025
Q3 		$720K Sell
1,838
-465
-20% -$194K 0.01% 375
2025
Q2 		$1.03M Sell
2,303
-1,094
-32% -$504K 0.02% 320
2025
Q1 		$1.65M Sell
3,397
-1,666
-33% -$776K 0.03% 254
2024
Q4 		$2.04M Sell
5,063
-131
-3% -$60.7K 0.03% 235
2024
Q3 		$2.42M Sell
5,194
-32
-0.6% -$15.4K 0.04% 221
2024
Q2 		$2.45M Sell
5,226
-1,166
-18% -$506K 0.04% 221
2024
Q1 		$2.67M Sell
6,392
-30,103
-82% -$12.7M 0.04% 211
2023
Q4 		$14.8M Sell
36,495
-2,109
-5% -$779K 0.22% 94
2023
Q3 		$13.4M Sell
38,604
-3,798
-9% -$1.33M 0.22% 99
2023
Q2 		$14.9M Buy
42,402
+300
+0.7% +$101K 0.23% 99
2023
Q1 		$13.3M Sell
42,102
-1,306
-3% -$392K 0.21% 107
2022
Q4 		$12.5M Buy
43,408
+1,042
+2% +$318K 0.2% 111
2022
Q3 		$12.3M Buy
42,366
+21,362
+102% +$6.15M 0.21% 110
2022
Q2 		$5.92M Buy
21,004
+20,829
+11,902% +$5.58M 0.09% 175
2022
Q1 		$46K Buy
175
+1
+0.6% +$237 ﹤0.01% 993
2021
Q4 		$38K Buy
+174
New +$33.8K ﹤0.01% 1073

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

UMB Bank's VRTX Position: Q2 2026 in Review

UMB Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 9.2% in Q2 2026, selling an estimated $65.6K and leaving 1,459 shares worth $725K. The position accounts for 0.01% of the portfolio, ranked #414.

UMB Bank first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $14.9M in Q2 2023. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • UMB Bank held 1,459 shares of Vertex Pharmaceuticals worth $725K as of Q2 2026.
  • UMB Bank sold 148 Vertex Pharmaceuticals shares in Q2 2026, an estimated $65.6K.
  • Vertex Pharmaceuticals made up 0.01% of UMB Bank's portfolio in Q2 2026, its #414 holding.
  • UMB Bank first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • UMB Bank's Vertex Pharmaceuticals position peaked at $14.9M in Q2 2023.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.